Ligand validation:4AYT

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 4AYT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AYT_CDL_A_1721	28%	67%	0.237	0.938	0.66	0.62	2	4	7	1	74%	0.5
4AYT_CDL_A_1727	14%	52%	0.181	0.879	0.86	1.01	1	2	0	0	18%	1
3ZDQ_CDL_A_1721	37%	64%	0.215	0.943	0.72	0.65	4	4	28	1	84%	0.5
4AYX_CDL_A_1721	13%	67%	0.262	0.853	0.66	0.62	2	4	6	1	74%	0.5
9GCX_CDL_C_504	62%	68%	0.143	0.934	0.43	0.79	-	2	16	0	100%	1
4D6U_CDL_G_501	57%	27%	0.081	0.955	1.5	1.44	4	6	0	0	44%	1
7C52_CDL_M_406	55%	46%	0.118	0.886	0.93	1.14	4	7	7	0	100%	1
9IKG_CDL_L_101	53%	71%	0.147	0.919	0.41	0.7	-	4	4	0	94%	1
9KUM_CDL_L_101	52%	72%	0.144	0.913	0.45	0.63	-	2	6	0	94%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.